Patent US5914345A successfully refreshed from Google Patents.
← Back to Patent Explorer
US5914345A Expired / Lapsed US ⏱️ 0.0 years remaining

Treatment of tissues to reduce subsequent response to injury

Assignee: Endoluminal Therapeutics Inc
•
Filing: 1994-10-11
•
Granted: 1999-06-22
•
Expires: 2014-10-11
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract An exogenous stimulus is applied to tissues or cells which are at risk in a subsequent surgical procedure or other intervention which induces a response by the cells that minimizes reaction to the subsequent procedure. Stimuli can be chemical, physiological or physical. Examples include those stimuli known to induce expression of stress response proteins or heat shock proteins, especially heat shock protein 70 (hsp 70) and hsp 90, for example, exposure to heat or dilute hydrogen peroxide, or direct administration of exogenous heat shock proteins, or those stimuli which act to inhibit or reduce heat shock protein expression, for example, treatment with flavonoids. An amount effective to modulate levels of stress response proteins or reduce the endogenous response is administered, based on in vitro assays which are used to determine levels of heat shock proteins or which are experimentally determined to reduce cell proliferation, thrombus formation, and matrix deposition following subsequent exposure to a procedure. Procedures can be surgery, angioplasty, or abrasion. The method and compositions are also useful in mediating some disease processes, where the process involves undesirable migration.

Inventors

  • 👤 Marvin J. Slepian
  • 👤 Stephen P. Massia

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 14:22
CPC Classifications
A; A61; A61K; A61K41/00; A61K41/0023; A61P; A61P39/00; A61P43/00; A61P7/00; A61P7/02

Claims Analysis

Total Claims: 26
Claim 1
Independent Claim 65 words
A method for altering subsecuent cellular responses to a therapeutic intervention at a tissue locus in vivo, the method comprising treating the cells at the tissue locus prior to the intervention with a stimulus which can induce altered levels of stress response or heat shock proteins in the cells in an amount effective to alter proliferation and migration of the cells resulting from the intervention.
Claim 2
Independent Claim 65 words
A method for altering subsecuent cellular responses to a therapeutic intervention at a tissue locus in vivo, the method comprising treating the cells at the tissue locus prior to the intervention with a stimulus which can induce altered levels of stress response or heat shock proteins in the cells in an amount effective to alter proliferation and migration of the cells resulting from the intervention.
Claim 3
Dependent Claim 47 words
The method of claim 1 wherein the stimulus is a physical stimulus selected from the group consisting of heat, cold, ultrasound, light, vibration, and pressure in an amount effective to induce expression of stress response proteins or heat shock proteins without killing the cells to be treated.
Claim 4
Dependent Claim 23 words
The method of claim 1 wherein the stimulus is a physiological stimulus selected from the group consisting of glucose deprivation and oxygen deprivation.
Claim 5
Dependent Claim 44 words
The method of claim 1 wherein the stimulus is a chemical stimulus selected from the group consisting of oxidants and heavy metals in an amount effective to induce expression of stress response proteins or heat shock proteins without killing the cells to be treated.
Claim 6
Dependent Claim 29 words
The method of claim 1 wherein the stimulus is a flavonoid in an amount effective to reduce expression of heat shock proteins without killing the cells to be treated.
Claim 7
Dependent Claim 22 words
The method of claim 1 wherein the treated cells exhibit decreased proliferation as compared with untreated cells following exposure to said stimulus.
Claim 8
Dependent Claim 13 words
The method of claim 6 wherein the therapeutic treatment is a surgical intervention.
Claim 9
Dependent Claim 28 words
The method of claim 7 wherein the surgical intervention is angioplasty, atherectomy, stenting, coronary artery bypass grafting, peripheral arterial bypass grafting, stent graft placement, or prosthetic graft placement.
Claim 10
Dependent Claim 23 words
The method of claim 1 wherein the cells exhibit decreased migration after treatment as compared with untreated cells following exposure to the stimulus.
Claim 11
Dependent Claim 11 words
The method of claim 9 wherein the cells are transformed cells.
Claim 12
Dependent Claim 22 words
The method of claim 1 wherein the stimulus is applied in combination with a polymeric material to the cells to be treated.
Claim 13
Dependent Claim 25 words
The method of claim 11 wherein the polymeric material is selected from the group of polymeric materials consisting of hydrogels, organogels, polymeric films, and microparticles.
Claim 14
Dependent Claim 21 words
The method of claim 1 wherein the stimulus is the application of exogenous purified stress response proteins or heat shock proteins.
Claim 15
Dependent Claim 14 words
The method of claim 13 wherein the stress response proteins are heat shock proteins.
Claim 16
Dependent Claim 17 words
The method of claim 1 wherein the stimulus is applied continuously prior to and during the intervention.
Claim 17
Dependent Claim 20 words
The method of claim 1 further comprising treating the cells with the stimulus at the tissue locus after the intervention.
Claim 18
Dependent Claim 10 words
The method of claim 1 wherein the intervention is surgery.
Claim 19
Dependent Claim 11 words
The method of claim 1 wherein the stimulus is systemically applied.
Claim 20
Dependent Claim 11 words
The method of claim 1 wherein the stimulus is locally applied.
Claim 21
Dependent Claim 27 words
The method of claim 1 wherein the method further comprises injuring the cells at the tissue locus during the intervention after treating the cells with the stimulus.
Claim 22
Dependent Claim 12 words
The method of claim 20 wherein the intervention is a surgical intervention.
Claim 23
Dependent Claim 28 words
The method of claim 21 wherein the surgical intervention is angioplasty, atherectomy, stenting, coronary artery bypass grafting, peripheral arterial bypass grafting, stent graft placement, or prosthetic graft placement.
Claim 24
Dependent Claim 11 words
The method of claim 22 wherein the surgical intervention is angioplasty.
Claim 25
Dependent Claim 12 words
The method of claim 1 wherein the tissue is a blood vessel.
Claim 26
Dependent Claim 12 words
The method of claim 23 Wherein the tissue is a blood vessel.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 2002-06-21 2002-12-21 2003-06-22 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2006-06-21 2006-12-21 2007-06-22 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2010-06-21 2010-12-21 2011-06-22 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag